Cargando…

Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life

BACKGROUND: Characterizing the dynamics of serum creatinine concentrations (Scr) and associated creatinine clearance (CLcr) as a measure of kidney function in extremely low birth weight (≤ 1000 g; ELBW) neonates remains challenging. METHODS: We performed a retrospective study that included longitudi...

Descripción completa

Detalles Bibliográficos
Autores principales: van Donge, Tamara, Allegaert, Karel, Gotta, Verena, Smits, Anne, Levtchenko, Elena, Mekahli, Djalila, van den Anker, John, Pfister, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851041/
https://www.ncbi.nlm.nih.gov/pubmed/32944826
http://dx.doi.org/10.1007/s00467-020-04749-3
_version_ 1783645561506758656
author van Donge, Tamara
Allegaert, Karel
Gotta, Verena
Smits, Anne
Levtchenko, Elena
Mekahli, Djalila
van den Anker, John
Pfister, Marc
author_facet van Donge, Tamara
Allegaert, Karel
Gotta, Verena
Smits, Anne
Levtchenko, Elena
Mekahli, Djalila
van den Anker, John
Pfister, Marc
author_sort van Donge, Tamara
collection PubMed
description BACKGROUND: Characterizing the dynamics of serum creatinine concentrations (Scr) and associated creatinine clearance (CLcr) as a measure of kidney function in extremely low birth weight (≤ 1000 g; ELBW) neonates remains challenging. METHODS: We performed a retrospective study that included longitudinal Scr (enzymatic assay) data from 148 ELBW neonates up to 6 weeks after birth. Change of Scr and inter-individual variability was characterized with nonlinear mixed-effect modeling. Key covariates such as gestational age (GA), mode of delivery (MOD), and treatment with ibuprofen or inotropic agents were investigated. RESULTS: A total of 2814 Scr concentrations were analyzed. GA was associated with Scr at birth (higher with advancing GA), and GA and MOD showed an association with postnatal maturation of CLcr (faster clearance increase with advancing GA and after C-section). Small CLcr decrease (≤ 5%) was quantified during ibuprofen treatment. For a GA of 27 weeks, mean Scr (estimated CLcr) at birth was 0.61 mg/dl (0.23 ml/min), increasing to 0.87 mg/dl (0.27 ml/min) at day three, and decreasing to 0.36 mg/dl (0.67 ml/min) at day 42 after birth. CONCLUSIONS: We report the first mathematical model able to characterize Scr and CLcr in ELBW neonates during the first 6 weeks of life in a quantitative manner as a function of GA, MOD, and ibuprofen treatment. This model allows the derivation of GA-adjusted reference ranges for ELBW neonates and provides a rationale for normative Scr concentrations, and as such will help clinicians to further optimize monitoring and treatment decisions in this vulnerable patient population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00467-020-04749-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7851041
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-78510412021-02-08 Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life van Donge, Tamara Allegaert, Karel Gotta, Verena Smits, Anne Levtchenko, Elena Mekahli, Djalila van den Anker, John Pfister, Marc Pediatr Nephrol Original Article BACKGROUND: Characterizing the dynamics of serum creatinine concentrations (Scr) and associated creatinine clearance (CLcr) as a measure of kidney function in extremely low birth weight (≤ 1000 g; ELBW) neonates remains challenging. METHODS: We performed a retrospective study that included longitudinal Scr (enzymatic assay) data from 148 ELBW neonates up to 6 weeks after birth. Change of Scr and inter-individual variability was characterized with nonlinear mixed-effect modeling. Key covariates such as gestational age (GA), mode of delivery (MOD), and treatment with ibuprofen or inotropic agents were investigated. RESULTS: A total of 2814 Scr concentrations were analyzed. GA was associated with Scr at birth (higher with advancing GA), and GA and MOD showed an association with postnatal maturation of CLcr (faster clearance increase with advancing GA and after C-section). Small CLcr decrease (≤ 5%) was quantified during ibuprofen treatment. For a GA of 27 weeks, mean Scr (estimated CLcr) at birth was 0.61 mg/dl (0.23 ml/min), increasing to 0.87 mg/dl (0.27 ml/min) at day three, and decreasing to 0.36 mg/dl (0.67 ml/min) at day 42 after birth. CONCLUSIONS: We report the first mathematical model able to characterize Scr and CLcr in ELBW neonates during the first 6 weeks of life in a quantitative manner as a function of GA, MOD, and ibuprofen treatment. This model allows the derivation of GA-adjusted reference ranges for ELBW neonates and provides a rationale for normative Scr concentrations, and as such will help clinicians to further optimize monitoring and treatment decisions in this vulnerable patient population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00467-020-04749-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-09-17 2021 /pmc/articles/PMC7851041/ /pubmed/32944826 http://dx.doi.org/10.1007/s00467-020-04749-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
van Donge, Tamara
Allegaert, Karel
Gotta, Verena
Smits, Anne
Levtchenko, Elena
Mekahli, Djalila
van den Anker, John
Pfister, Marc
Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life
title Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life
title_full Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life
title_fullStr Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life
title_full_unstemmed Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life
title_short Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life
title_sort characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851041/
https://www.ncbi.nlm.nih.gov/pubmed/32944826
http://dx.doi.org/10.1007/s00467-020-04749-3
work_keys_str_mv AT vandongetamara characterizingdynamicsofserumcreatinineandcreatinineclearanceinextremelylowbirthweightneonatesduringthefirst6weeksoflife
AT allegaertkarel characterizingdynamicsofserumcreatinineandcreatinineclearanceinextremelylowbirthweightneonatesduringthefirst6weeksoflife
AT gottaverena characterizingdynamicsofserumcreatinineandcreatinineclearanceinextremelylowbirthweightneonatesduringthefirst6weeksoflife
AT smitsanne characterizingdynamicsofserumcreatinineandcreatinineclearanceinextremelylowbirthweightneonatesduringthefirst6weeksoflife
AT levtchenkoelena characterizingdynamicsofserumcreatinineandcreatinineclearanceinextremelylowbirthweightneonatesduringthefirst6weeksoflife
AT mekahlidjalila characterizingdynamicsofserumcreatinineandcreatinineclearanceinextremelylowbirthweightneonatesduringthefirst6weeksoflife
AT vandenankerjohn characterizingdynamicsofserumcreatinineandcreatinineclearanceinextremelylowbirthweightneonatesduringthefirst6weeksoflife
AT pfistermarc characterizingdynamicsofserumcreatinineandcreatinineclearanceinextremelylowbirthweightneonatesduringthefirst6weeksoflife